ExesaLibero Pharma receives Innovation Award at the 2022 TechConnect Conference
ExesaLibero Pharma, received an Innovation Award at the 2022 TechConnect Conference DC held in Washington DC June 13 & 14, 2022.
TechConnect DC is the nation's largest gathering of researchers, entrepreneurial innovators, industry scouts, and federal funding agencies.
As awardees, ExesaLibero had the opportunity to present their project "Development of the haloanilide, ELP-004 to prevent arthritis-induced bone erosion by inhibiting osteoclast differentiation" and received onsite feedback from a panel representing leaders in the industry, investment, government, and military. Awardees also hosted a showcase table at the conference ExesaLibero Pharma, for receiving an Innovation Award at the 2022 TechConnect Conference.